Back
CRISPR Therapeutics AG Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
$56.81
Seasonality Move:
-15.72%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.26 | Buy |
20-day SMA: | 47.89 | Buy |
50-day SMA: | 41.76 | Buy |
200-day SMA: | 43.41 | Buy |
8-day EMA: | 54.1 | Buy |
20-day EMA: | 49.19 | Buy |
50-day EMA: | 42.31 | Buy |
200-day EMA: | 22.08 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.53 | Buy |
Relative Strength Index (14 RSI): | 80.69 | Buy |
Chaikin Money Flow: | -2127195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.76 - 52.16) | Buy |
Bollinger Bands (100): | (35.54 - 46.9) | Buy |
CRISPR Therapeutics AG Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 59.00 while CRSP 8-day simple moving average is 53.26, which is a Buy signal.
-
The stock price of CRSP is 59.00 while CRISPR Therapeutics AG 20-day SMA is 47.89, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 41.76 while CRSP share price is 59.00, making it a Buy technically.
-
CRSP stock price is 59.00 and CRISPR Therapeutics AG 200-day simple moving average is 43.41, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $59.00. The Score for CRSP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.1B
Price in USD:
59.00
Share Volume:
4.6M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
63.68
52-Week Low:
30.04
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 59.00 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 59.00 while CRSP 8-day exponential moving average is 54.10, which is a Buy signal.
-
The stock price of CRSP is 59.00 while CRISPR Therapeutics AG 20-day EMA is 49.19, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 42.31 while CRSP share price is 59.00, making it a Buy technically.
-
CRSP stock price is 59.00 and CRISPR Therapeutics AG 200-day simple moving average is 22.08, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.23 per share, and an increase next year of $0.87 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 4.53, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 80.69, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (40.76 - 52.16), which suggest CRISPR Therapeutics AG is a Buy
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (35.54 - 46.9), which suggest CRISPR Therapeutics AG is a Buy
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.